Form 4 for MNOV MEDICINOVA INC
Accepted 2021-08-25 00:00:00 ET · period of report 2021-08-23 · accession 0001683168-21-003893 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-25 | 2021-08-23 | MNOV | Matsuda Kazuko | Chief Medical Off, Dir | M - OptEx | $2.30 | +60.0K | 323.0K | +23% | +$138.0K |
| D | 2021-08-25 | 2021-08-23 | MNOV | Matsuda Kazuko | Chief Medical Off, Dir | M - OptEx | $0.00 | -60.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-23 | M | A | 60,000 | $2.30 | 322,996 | D | — | — | |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2021-08-23 | M | D | 60,000 | $0.00 | 0 | D | $2.30 · — to 2021-08-31 | 60,000 Common Stock | (F1) The option vested over a period of 4 years in equal monthly installments from the 9/1/2011 date of grant and is now fully vested. |